Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation

Conventional CD4 T cells represent a major source of inflammatory mediators that drive progression of chronic liver disease to fibrosis and to end-stage cirrhosis. Identification of T cell pathways that limits the inflammatory response could thus have therapeutic relevance. Here we show, using both human samples and mouse models, that autophagy is deficient in CD4 T cells from patients with advanced fibrosis, and that loss of autophagy following genomic deletion of ATG5 in T cells is associated with the emergence of pathogenic IL-17A + IFN-γ + Th17 T cells that drive liver fibrosis in mice. Mechanistically, liver CD4 T cells lacking autophagy display a Th17 glycolytic phenotype associated with enhanced type 3 cytokine (i.e., IL-17A and GM-CSF) release, shifting hepatic myofibroblasts, hepatocytes and macrophages toward a proinflammatory phenotype. We also show that autophagy can be rescued in CD4 T cells from patients with extensive liver fibrosis, leading to decreased frequency of pathogenic Th17 cells and reduced GM-CSF levels; in addition, limited fibrosis is observed in mice in which Rubicon, a negative regulator of autophagy, is deleted specifically in their T cells. Our findings thus implicate autophagy in CD4 T cells as a key therapeutic target to control inflammation-driven fibrosis during chronic liver injury.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-24
DOI
https://doi.org/10.1038/s41467-025-59218-y
Citations
8
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
10.83

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation

Charles Caër, Rémy Nicolle, Hélène Gilgenkrantz, Sukriti Baweja et al.
8 citations
Nature Communications
Autophagy in Disease and Therapy
10.83
article

Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation

Charles Caër, Rémy Nicolle, Hélène Gilgenkrantz, Sukriti Baweja, Sophie Lotersztajn, Adel Hammoutène, Tristan Thibault-Sogorb, Valérie Paradis, Loredana Saveanu, Emmanuel Weiss, JingHong Wan, Janany Kandiah, Morgane Mabire, Camille Pignolet, Rola Al Sayegh, Mathilde Cadoux, Margot Azoulai, Maxime Gasperment, Marc-Anthony Chouillard
article en
8 citations

Abstract

Conventional CD4 T cells represent a major source of inflammatory mediators that drive progression of chronic liver disease to fibrosis and to end-stage cirrhosis. Identification of T cell pathways that limits the inflammatory response could thus have therapeutic relevance. Here we show, using both human samples and mouse models, that autophagy is deficient in CD4 T cells from patients with advanced fibrosis, and that loss of autophagy following genomic deletion of ATG5 in T cells is associated with the emergence of pathogenic IL-17A + IFN-γ + Th17 T cells that drive liver fibrosis in mice. Mechanistically, liver CD4 T cells lacking autophagy display a Th17 glycolytic phenotype associated with enhanced type 3 cytokine (i.e., IL-17A and GM-CSF) release, shifting hepatic myofibroblasts, hepatocytes and macrophages toward a proinflammatory phenotype. We also show that autophagy can be rescued in CD4 T cells from patients with extensive liver fibrosis, leading to decreased frequency of pathogenic Th17 cells and reduced GM-CSF levels; in addition, limited fibrosis is observed in mice in which Rubicon, a negative regulator of autophagy, is deleted specifically in their T cells. Our findings thus implicate autophagy in CD4 T cells as a key therapeutic target to control inflammation-driven fibrosis during chronic liver injury.

Nature CommunicationsVol. 16(1)
Inserm (FR), Université Paris Cité (FR), Hôpital Beaujon (FR), Assistance Publique – Hôpitaux de Paris (FR), Institute of Liver and Biliary Sciences (IN), Centre de Recherche sur l'Inflammation (FR)
Laboratoire d'Excellence Inflamex, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation ARC pour la Recherche sur le Cancer, Institut National Du Cancer, Direction Générale de l’offre de Soins
Good health and well-being
Openalex Percentile: Top 1%
Autophagy in Disease and Therapy
10.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.